Romaco: System Solution with Patented In-Line Scale
At the forthcoming POWTECH 2014, Romaco Kilian will show the Kilian KTP 420X tablet press with the patented in-line continuous weight control (CWC). The engineering specialist’s new KTP 420X series is an innovative generation of flexible, high speed tablet presses for the pharmaceutical industry.
The Romaco Kilian KTP 420X is a versatile, high speed tablet press which, in combination with the new CWC system, will be Romaco’s highlight at this year’s POWTECH. This groundbreaking machine, equipped with numerous patented features, compresses up to 360,000 tablets an hour. The Kilian KTP 420X is ideal for the production of mono-layer, bi-layer or core tablets (tab-in-tab), and it can also be used to process poorly flowing materials. It is characterised by high effective availability, low costs for maintenance and spare parts and very simple handling. The Kilian KTP 420X is winner of this year’s iF Award for innovative design.
Patented Features
The patented CWC in-line scale allows the weight of the tablet being produced to be measured continuously at the discharge as the products are pressed without destroying them. The KTP 420X makes Romaco Kilian the first manufacturer worldwide to offer a solution for continuous weight control. The weighed tablets are placed in the “good” channel using compressed air. As a result of the new process, there is no longer any need to make sample tablets to check the weight and product loss is reduced to zero. This automatic weight control system helps to avoid unnecessary costs, especially when processing expensive (active) ingredients.
One tablet is measured per turret revolution with an accuracy of 0.1 mg. The CWC system is fully integrated in the PLC and operated over the HMI (human machine interface) panel. The results of the measurements can be leveraged directly to control the machine and greatly improve the reliability of the process. CWC can be supplied as an option for all models in the KTP 420X and KTP 720X series and is also available as a retrofit kit.
High Flexibility and Low Total Cost of Ownership
The wear-free torque motor, extremely durable compression rollers and wear-free lower punch brakes with patented magnets underlie the very low total cost of ownership. The likewise patented punch bellows protect the tablets from lubricants. Thanks to the hermetic separation of the compaction and service areas, no product or oil gets into the machine compartment of the press. The optimised hygienic design permits quick and easy cleaning. At the same time the new, ergonomic, Windows 7 based HMI panel guarantees reliable handling. The significant reduction in press noise adds to the user friendly working environment.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.